trending Market Intelligence /marketintelligence/en/news-insights/trending/4t-3mR371M7UA3TkH1zCTw2 content esgSubNav
In This List

ContraVir names board member

Blog

Insight Weekly: M&A players predict 2023 activity; SPAC IPOs dip; 2022 capacity retirements up

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share


ContraVir names board member

ContraVir Pharmaceuticals Inc. appointed Tamar Howson to its board.

Howson previously served as senior vice president of corporate and business development at both GlaxoSmithKline PLC and Bristol-Myers Squibb Co.